Skip to content
naulon

No retraction, correction or concern found when last checked on Oct 24, 2026.

Single-cell lipidomics with high structural specificity by mass spectrometry

Zishuai Li, Simin Cheng, Qiaohong Lin and 8 more

Nature Communications · 2021 · CC BY

doi:10.1038/s41467-021-23161-5

Abstract

Single-cell analysis is critical to revealing cell-to-cell heterogeneity that would otherwise be lost in ensemble analysis. Detailed lipidome characterization for single cells is still far from mature, especially when considering the highly complex structural diversity of lipids and the limited sample amounts available from a single cell. We report the development of a general strategy enabling single-cell lipidomic analysis with high structural specificity. Cell fixation is applied to retain lipids in the cell during batch treatments prior to single-cell analysis. In addition to tandem mass spectrometry analysis revealing the class and fatty acyl-chain for lipids, batch photochemical derivatization and single-cell droplet treatment are performed to identify the C=C locations and sn -positions of lipids, respectively. Electro-migration combined with droplet-assisted electrospray ionization enables single-cell mass spectrometry analysis with easy operation but high efficiency in sample usage. Four subtypes of human breast cancer cells are correctly classified through quantitative analysis of lipid C=C location or sn -position isomers in ~160 cells. Most importantly, the single-cell deep lipidomics strategy successfully discriminates gefitinib-resistant cells from a population of wild-type human lung cancer cells (HCC827), highlighting its unique capability to promote precision medicine.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 24, 2026. Paragraph numbers are ours, so an answer can point at one.

Introduction

Single-cell analysis is essential for the study of many fundamental biological phenomena, revealing the cellular heterogeneity during cell development. Multifarious techniques have been developed for applying various omics for single cell analysis, including genomics, proteomics, and metabolomics–. Among those omics, the proteome and metabolome respond to external stimuli more rapidly and usually are harder to be detected or identified due to their complex structures and low biomarker abundances in a single cell. Mass spectrometry (MS) has become a method of choice for single-cell metabolome analysis in consideration of its high sensitivity and high structural identification capabilities–.

However, comprehensive structural characterization and quantitation of a relatively large number of metabolites, for example, lipids, is still difficult at the single-cell level. The chemical structures of lipids are very complex and a significant amount of efforts have been put in the discovery of interesting chemistry (e.g., photochemical reactions and epoxidation) for elucidating lipid structures using MS. Paternò–Büchi (PB) reaction combined with tandem MS is one of the most effective protocols for the detailed characterization and relative quantitation of lipids at carbon–carbon double bond (C=C) location and sn-position levels–. Epoxidation is also common in deep lipidomic analysis with C=C location specificity, owing to its universal accessibility–. The composition of C=C location isomers or sn-position isomers from human plasma, tissues and cell populations have been obtained using these chemical derivatizations–. In the past few years, some MS analysis methods have been developed to profile lipids in single cells, such as inkjet printed microarrays, probe ESI (electrospray ionization), single-probe MS, T probe, secondary ion MS, matrix-assisted laser desorption/ionization (MALDI) MS, and cyESI-MS. The requirement of special media solutions and devices, however, hindered the coupling of chemical derivatization with these methods. MS image of lipid C=C location isomers by PB-MALDI-MS/MS has been reported at the resolution of single-cell size,, but this image could not point to the cell accurately due to the differences between regular image pixel and irregular cell morphology. Recently, MS method coupled with PB reaction were reported to identify C=C locations of lipids in single cell, but relative quantitation of isomers has never been done and its unique biological significance was not demonstrated.

In this work, we develop a protocol with shotgun MS analysis for single-cell lipidomics with high structural specificity including C=C locations or sn-positions (Fig. 1a). The cells are first fixed by glutaraldehyde to prevent cell lysis in salt-free solution. Batch photochemical derivatization (PB reaction with hydro-soluble 2-acetylpyridine) are performed to allow a comprehensive lipid characterization with C=C location specificity through later single-cell MS/MS analysis. The sn-position of phosphatidylcholines (PCs) are obtained through MS/MS analysis of bicarbonate adduct ions. The relative quantitation of the major lipid C=C location and sn-position isomers reveals the degree of heterogeneity differences among four human breast cancer cell lines, including MDA-MB-231, MDA-MB-468, MCF-7, and BT-474. The distinct capability of the developed method is that only the relative quantitation of lipid C=C location isomers can discriminate gefitinib-resistant single cells in wild-type non-small-cell lung cancer (NSCLC) cell population, demonstrating its unique significance for precision medicine.

Cell fixation, cell manipulation, and collective derivatization

An efficient method for cell manipulation and subsequent MS analysis based on electro-migration and electroporation was previously developed for analyzing cells with cell walls, including fungus, algae, and protozoa. However, to extend this method for mammalian cells, isotonic buffer (e.g., phosphate-buffered saline, PBS) needs to be used to prevent the lysis of the cell membrane, which is incompatible with electrospray ionization. To circumvent this problem and confine lipids within the cell through the batch cell manipulation and derivatization prior to MS analysis, cell fixation was proposed as the first step of the analysis procedure. During fixation, amines in cellular proteins react with glutaraldehyde to form cross-linked proteins in cytoskeleton, which effectively prevents the cell lysis in water. By using precursor ion scan of m/z 184, it was demonstrated that the recovery of PCs after fixation was more than 90% (Fig. 1c, d and Supplementary Fig. 1a–d). The recovery ratio was not influenced by the concentration of the cells (Supplementary Fig. 1e, f). It should be noted that lipids containing amine groups, like PEs, would be lost, due to their reactions with glutaraldehyde (Supplementary Fig. 1g, h). This fixation made it possible to manipulate a single mammalian cell in salt-free solvents such as pure water, which is more friendly to ESI-MS analysis in comparison with PBS.

For lipid structure identification, chemical derivatization such as PB reaction was particularly useful; however, this would cause damages to the cell membrane, leading to cell lysis and cross-contaminations among single cells during lipid derivatization process. This problem could now be solved with the cell fixation, which also provided a relatively high local concentration of lipids for PB reaction. In previous studies for lipid analysis involving PB reactions, acetone was one of the most popular derivatizing reagents for the identification and relative quantitation of unsaturated lipids. However, acetone was usually used at relatively high percentages, which would lead to the breakdown of cell membrane. Ideally, to avoid lipid dissolution and diffusion, lipid derivatization should be carried out in an aqueous environment. We therefore chose a serials of hydro-soluble carbonyl compounds as PB reagents, including 2-acetylpyridine (2-AP), 3-AP, and 4-AP. Cells were derivatized in a quartz cell under 254 nm UV irradiation (Fig. 1d). Among all APs, 2-AP has the highest conversion yield (Supplementary Fig. 2a) and the corresponding PB product ion offers the highest relative intensities of the diagnostic ions as well (Supplementary Fig. 2b–d). Therefore, 2-AP was finally chosen for lipid derivatization in single cells, with an optimal reaction time of 8 min and an optimal concentration of 100 mM (Supplementary Fig. 2e, f). After derivatization, cells were washed twice using pure water to remove excess 2-AP and would be individually analyzed subsequently.

Single-cell MS analysis

Previously, we have developed method for manipulating and analyzing single cells using electro-migration. Using a modified method, individual cell could be sent to a capillary tip and multi-round sampling of the cell could be performed for MS or MS/MS data acquisition. Following the fixation, the cells were washed with water and then diluted to a concentration of ~ 104 cells/mL. For single-cell MS analysis, ~ 0.5 μL of cell suspension was transferred by pipette to a capillary with a pulled tip for nanoESI. To drive the cell to the front end of the capillary, a direct current (DC) voltage of −1.3 kV was applied by a stainless-steel electrode (Fig. 1b). To achieve a better sample consumption efficiency, following the solvent evaporation in the nanoESI tip, droplet-assisted electrospray ionization (DAESI) was used to enable single-cell MS analysis. The limit of detection of DAESI was reported to be 50 attomole, which is sensitive enough for single-cell analysis. A droplet (~50 μL) of assistant solvent (methanol:acetonitrile = 1:1 (v/v) with 1% formic acid) was applied to the front of the capillary to initiate DAESI of the single cell. Such a solvent condition has been demonstrated to be efficient for both lipid extraction and nanoESI. The sample ionization could be readily synchronized with ion introduction for mass analysis so the sample consumption was reduced. A variety of PCs were detected with high abundances from single mammalian cells, e.g., the human breast cancer cells MDA-MB-231 (Fig. 2a). As for analysis of single cells after photochemical derivatization, the peaks of PB products of unsaturated lipids (marked as PBM) were clearly observed, each with a m/z value increase of 121 Da (Fig. 2b). The ion intensity of PB products was even a little higher than that of the corresponding intact lipid, possibly due to the higher proton affinity of the pyridine in 2-AP. Changes in the relative intensity of sodium and proton adduct ions of PCs before and after PB reaction are possibly due to solution acidification after PB reaction and variation of sodium in cells.

It has been reported that DAESI can enable high MS sensitivity at reduced sample consumption, lipids and their PB products from a single cell could be more effectively detected and structurally characterized. In addition, multiple rounds of sampling of an individual cell could be performed using DAESI, since the compounds were only consumed when the assisted droplet was applied, which was operated in an on-demand ionization mode. In the analysis of a derivatized single MDA-MB-231 cell, for instance, even upon the 8th sampling, the signal-to-noise ratios (S/N ratios) of PB products for PC 34:1 and PC 36:2 (at m/z 881.7 and 907.8) were still high enough for MS/MS analysis (Fig. 2c, d). The spectra of other spray could be seen in Supplementary Fig. 3a. Pairwise correlation coefficients calculated using the intensities of PB product ions of each spray were ≥0.85 among the first 8 sprays (Fig. 2e). This experiment was repeated 5 times and the results were similar (Supplementary Fig. 3b–i), indicating that at least 8 species of lipids of various m/z values could be readily analyzed from a single MDA-MB-231 cell by 8 rounds of sampling. The MS/MS spectra of the PB products of PC 32:1, PC 33:1, PC 35:2, PC 36:2, PC 36:1, PC 34:2, and PC 34:1 from a single MDA-MB-231 cell were shown in Supplementary Fig. 4. This demonstrated that detailed lipid structure analysis at the single-cell level could now be performed through chemical derivatization and tandem MS.

Lipid structural elucidation in single cells

Coupling with tandem MS, the C=C location(s) in unsaturated lipids could be readily identified. For instance, the pair of diagnostic ions at m/z 650 and m/z 739 were used to pinpoint a Δ9 C=C in PC 16:0_18:1 (m/z 760), following collision-induced dissociation (CID) of the corresponding products (Supplementary Fig. 5). Three C=C location isomers could be detected for PC 16:0_18:1, with the C=C in C18:1 at Δ8, Δ9, and Δ11 as confirmed by diagnostic ions at m/z 636/725, 650/739, and 678/767, respectively (Fig. 3a). Moreover, the relative intensities of these C=C-specific diagnostic ions allowed relative quantitation of the corresponding lipid C=C location isomers.

Prior to locating the C=C bond in a fatty acyl-chain, negative MS/MS analysis of [PC + CH3COO]− ions from the extract of MDA-MB-231 cells was performed to identify the two fatty acyls. For instance, negative MS/MS analysis of [PC 34:1 + CH3COO]− (m/z 818) in MDA-MB-231 cell extract showed that the unsaturated fatty acyl in PC 34:1 was C18:1 (major) or C16:1 (minor) (Supplementary Fig. 6a–c). It should be noted that these diagnostic ions could not be used for relative quantitation due to their varied collision efficiencies. These negative MS/MS experiments were also performed at the single-cell level and the results of the major fatty acyl-chain compositions of the lipids in single cells were identical to those in the cell extract (Supplementary Fig. 6d–i).

MS/MS analysis of the corresponding PB products, for example [PB(PC 34:1) + H]+ (m/z 881), pinpointed the C=C location in C18:1 from PC 34:1 to be at Δ8, Δ9, or Δ11 (Fig. 3a). Similarly, MS/MS spectra of [PB(PC 36:2) + H]+ (m/z 907) indicated that unsaturated fatty acyls in PC 36:2 included C18:1(Δ8), C18:1(Δ9), C18:1(Δ11), and C18:2(Δ9, 12) (Supplementary Fig. 7). Other major fragments in Fig. 3a (m/z 822, 698, 680) were mainly fragments after neutral losses, for instance, of choline (59 Da) and PC headgroup (183 Da). The lowest abundance lipid detected with C=C locations was PC 38:2 (m/z 814) (Supplementary Fig. 10), whose intensity was ~5% of that of PC 34:1 (m/z 760.5) (Fig. 1c) and lipid with highest degree of unsaturation was PC 38:5 with 22 diagnostic ions (Supplementary Fig. 8). It is worth mentioning that the relative intensities of diagnostic ions acquired using in-trap CID were much higher than those acquired using beam-type CID (Supplementary Fig. 9). Therefore, all MS/MS analyses of PB products in this study were performed using in-trap CID unless otherwise stated. From single MDA-MB-231 cells, a total of at least 44 structurally defined molecular lipids with C=C locations from 14 sum compositions could be identified (Supplementary Fig. 10 and Supplementary Tables 1 and 2). For each individual cell, around 30 lipid C=C location isomers from 8 sum compositions could be detected by 8 rounds of sampling.

Besides PCs, other classes of lipids were also successfully detected from single cells, including fatty acids (FAs), diacylglycerols (DAGs), triacylglycerols (TAGs), and cholesteryl esters (CEs). FAs and neutral lipids, such as DAGs, TAGs, and CEs, were usually difficult to analyze directly in the positive ion mode. To our surprise, after derivatization these lipids became detectable in positive ion mode, owing to the introduction of a pyridine in PB products. For example, in single MCF-7 cells, positive MS/MS analysis of [PB(FA 18:1) + H]+ (m/z 404) revealed the C=C location in FA 18:1 to be at Δ9 or Δ11, with the two pairs of diagnostic ions at m/z 232/262 and 204/290 (Fig. 3b). Positive MS/MS analysis of [PB(DAG 18:1_18:1) + H]+ (m/z 742) indicated that C18:1 within DAG 18:1_18:1 could be either C18:1(Δ9) or C18:1(Δ11), with two corresponding pairs of diagnostic ions at m/z 493/600 and 521/628 (Fig. 3c). Positive MS/MS analysis of [PB(TAG 18:1_18:1_18:1) + H]+ (m/z 1006) indicated that C18:1 in TAG 18:1_18:1_18:1 could be either C18:1(Δ9) or C18:1(Δ11), with the two pairs of diagnostic ions at m/z 493/864 and 521/892 (Supplementary Fig. 11a). The diagnostic ions containing aldehyde observed for DAGs or TAGs were generated by a concomitant loss of water or a fatty acyl, respectively, after C=C cleavage. The MS/MS spectra of [PB(CE 18:1) + H]+ (m/z 772) indicated that the C=C locations in CE 18:1 were Δ9 or Δ11 with diagnostic ions at m/z 630 and 658 (Supplementary Fig. 11b). The characteristic fragment ion of CEs at m/z 369 was detected, which confirmed their presence. All these results demonstrated the ability of single-cell PB-MS/MS analysis for a variety of lipid classes.

In addition to the C=C locations, sn-positions of PCs in single cells could also be identified. It has been reported that the sn-position of PCs could be identified by negative mode MS/MS analysis with the adduct of bicarbonate anion (HCO3−). This method was adapted in this study for the single-cell lipid analysis by changing the assisted solvent to 50 mM ammonium bicarbonate solvent in methanol:acetonitrile:water = 4.5:4.5:1 (v/v). The bicarbonate anion was bound strongly with the phosphocholine head group and thus facilitated homolytic bond cleavage (C–N bond) and formation of radical ions upon CID, which generated diagnostic ions critical for identification of sn-isomers. As shown in Fig. 3d, two diagnostic ions with the m/z of 419 and 445 were detected, corresponding to PC 16:0/18:1 and PC 18:1/16:0, respectively. It should be noted that due to the lipid species limit of this methods we could only analyze the sn-position isomeric compositions of PCs in single cells. In summary, the developed protocol is enabling specificity of both C=C locations or sn-positions for single-cell lipidomic analysis.

Comparisons of the degree of cellular heterogeneities in human breast cancer cell lines

Breast cancer is the most frequent malignancy in women and is a heterogeneous disease at the cellular and molecular levels. To explore the lipidome heterogeneity at detailed-structure level among different breast cancer subtypes, other cell lines of MDA-MB-468, MCF-7 and BT-474 were also analyzed by the developed method. MDA-MB-231 and MDA-MB-468 were classified as triple-negative breast cancer cells, while MCF-7 and BT-474 were Luminal A type and Luminal B type, respectively. All the cell lines were subjected to the same process with cell fixation and lipid derivatization, and then analysis by MS (Supplementary Fig. 12). It is worth noting that in single intact MCF-7 cells, peaks isobaric to PB products of major PCs were detected, which were assigned to be TAGs via MS/MS analysis (Supplementary Fig. 13). Some odd-chain PCs were observed, which were consistent with previously published results for these cells,. Typical MS/MS spectra of [PCs + CH3COO]− in negative ion mode for these cells were shown in Supplementary Fig. 14. After PB-MS/MS analysis, tens of structurally defined molecular lipids with C=C location(s) specified were detected in each cell line (Table 1, Supplementary Fig. 15, and Supplementary Tables 3–8). To quantify the relative amounts of lipid C=C location isomers in different breast cancer cell lines, five PCs of high abundances, i.e., PC 32:1, PC 34:2, PC 34:1, PC 36:2, and PC 36:1, were analyzed for ~40 single cells of each subtype.

The relative amounts of C=C location isomers for each PC were shown in Fig. 4 and Supplementary Fig. 16, some of which were different among different cell lines (P-values in Supplementary Table 9). A t-distributed stochastic neighbor embedding (t-SNE) calculation allowed for successful classification of these four cell lines (Supplementary Fig. 17a).Cells analyzed were chosen stochastically, and such random sampling is speculated to reflect the whole cell population. For validation, we randomly selected two cell subsets containing 25 or 30 cells (Supplementary Fig. 17b, c) from each breast cancer cell line. The cell classification is also successful, indicating that such a sample size can be used to represent the whole population. Interestingly, the triple-negative breast cancer cell lines of MDA-MB-231 and MDA-MB-468 have completely different lipid composition in terms of C=C location and fatty acyl isomers, possibly due to genomic differences.

Remarkably, the means of the relative abundance of PC 34:2 with C16:1(Δ6) or C18:1(Δ8) in MDA-MB-468 and MCF-7 cells showed no significant statistical difference (P > 0.05, determined by two-tailed t-test) but the variances showed significant statistical difference (P < 0.001, determined by F-test). The variances could be used to test the degree of heterogeneity among single cells. As shown in Fig. 4c(i), the heterogeneity of the relative abundance of PC 34:2 with C16:1(Δ6) or C18:1(Δ8) in MDA-MB-468 single cells was higher than that in MCF-7 single cells. Same results were also observed in PC 32:1 and PC 36:2 with C16:1(Δ6) or C18:1(Δ8) (Supplementary Fig. 16). Similarly, the heterogeneity of the relative abundance of PC 34:2 with C16:1(Δ7) or C18:1(Δ9) in BT-474 single cells was higher than that in MCF-7 single cells (Fig. 4c(ii)). The heterogeneity of the relative abundance of PC 32:1 with C16:1(Δ7) or C18:1(Δ9) in BT-474 single cells was higher than that in MDA-MB-468 single cells (Supplementary Fig. 16). Besides, the mean and variance of the relative abundance of PC 16:0_18:2(Δ9, 12) showed no significant statistical difference (P > 0.05, mean determined by two-tailed t-test and variance determined by F-test) in MCF-7 and MDA-MB-231 single cells but their frequency distribution was quite different (Fig. 4d).

Subpopulation division could be used to test the heterogeneity among single cells. By multiple peaks fitting of the frequency histogram, we have revealed the variation of cell subpopulations. The relative abundance of the highest frequency in MCF-7 single cells was ~11.8% while that in MDA-MB-231 single cells was ~15.6% (Fig. 4d). The response of cellular lipidome to stearoyl-CoA desaturase (SCD1) inhibition of MDA-Mb-468 cell line was also studied at the single-cell level, demonstrating the capability of developed method to monitor the change of lipids at C=C location level (Supplementary Note 1). All these results demonstrated the capability of the developed method to probe the heterogeneities among single cells which were absent in cell population analysis.

In addition, we also performed relative quantitation of pairwise lipid sn-position isomers for the four breast cancer cell lines. It should be noted that negative mode MS/MS analysis of [PC + HCO3]− ions was only used for relative quantitation of lipid sn-position isomers with the same fatty acyl composition, excluding lipid fatty acyl isomers. We analyzed six pairs of lipid sn-position isomers (Supplementary Table 11) in the four breast cancer cell lines and the results (Supplementary Fig. 20) showed that some lipid sn-position isomers showed significant differences among these different subtypes (P-values in Supplementary Table 12). The relative abundance of lipid sn-position isomers could also be used to probe the degree of heterogeneity among single cells. For example, while the means of the relative abundance of PC 16:1/18:1 in MDA-MB-468 and BT-474 cells showed no significant differences (P > 0.05, determined by two-tailed t-test), the variances showed significant statistical difference (P < 0.001, determined by F-test), indicating a higher degree of heterogeneity among MDA-MB-468 cells (Supplementary Fig. 21a).The mean and variance of the relative abundance of PC 16:1/18:0 showed no significant statistical difference in MCF-7 and MDA-MB-468 (P > 0.05, mean determined by two-tailed t-test and variance determined by F-test). However, their frequency distributions were quite different, unimodal for MDA-MB-468 cells and bimodal for MCF-7 cells (Supplementary Fig. 21b). Moreover, t-SNE results calculated by relative quantitation of lipid sn-position isomers showed a lower degree of cell discrimination, compared with that using lipid C=C location isomers (Supplementary Fig. 17). These results indicated that the quantitative analysis of lipid C=C isomers allows a better discrimination of human breast cancer cells.

Single-cell lipidomics to discriminate drug-resistant cells from wild-type lung cell population

Lung cancer is the leading type of cancer-associated mortality worldwide and non-small-cell lung cancer (NSCLC) is the most common histological type of lung cancer. As an epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor, gefitinib is widely used as targeted therapy of NSCLC patients, which significantly improves the overall survival rate of lung cancer. However, some patients who initially respond well to gefitinib would develop acquired resistance. The discrimination of gefitinib-resistant and gefitinib-sensitive cells in NSCLC cell population was therefore very important for the precise treatment of NSCLC patients.

To explore whether lipid relative quantitation can be used to discriminate gefitinib-resistant and gefitinib-sensitive cells, which coexist in the wild-type NSCLC cell population, we chose two cell lines of HCC827 and HCC827/GR6 for analysis. HCC827 is a wild-type NSCLC cell line and HCC827/GR6 is a gefitinib-resistant cell line inherited from HCC827. The two cell lines were analyzed at the lipid profile, sn-position, and C=C location levels. Since lipids with both sodium and proton adduct were observed when 1% formic acid in methanol/acetonitrile = 1:1 (v/v) was used as the assisted solvent, which is undesirable for lipid relative quantitation, 10 mM LiCl in methanol/acetonitrile = 1:1 (v/v) was used instead to convert lipids to their lithium adducts. Twenty-seven lipid sum compositions were analyzed and some of them showed significant differences between the two cell lines (Supplementary Fig. 22 and P-values in Supplementary Table 13). However, after t-SNE calculation and unsupervised clustering (k-means), 16% of HCC827 and 19% of HCC827/GR6 cells were located in the cross-area of the two clusters, indicating a failed cell classification (Fig. 5a, d).

Lipid analysis at the sn-position level was also performed and only one pair of lipid sn-isomers (PC 16:1/18:0 and PC18:0/16:1) showed significant differences (Supplementary Fig. 23 and P-values in Supplementary Table 14). In the t-SNE plot, around 30% of the cells were located in the cross-area (Fig. 5b, d), also indicating a failed cell classification. Finally, we performed lipid analysis at the C=C location level and most of the 17 C=C location isomers detected from 5 lipid sum compositions (Supplementary Table 15) showed significant differences between HCC827 and HCC827/GR6 (Supplementary Fig. 24 and P-values in Supplementary Table 16). In the t-SNE plot, no cells exist in the cross-area (Fig. 5c, d), indicating a successful cell classification. Since ~98% of cells in Cluster 1 were from the HCC827 cell line and ~90% of cells in Cluster 2 were from the HCC827/GR6 cell line, we hypothesized that cells in Cluster 1 are gefitinib-sensitive while those in Cluster 2 are gefitinib-resistant. Remarkably, ~9% cells from the HCC827 cell line were determined as gefitinib-resistant, highly consistent with the reported percentages (7~12%) of gefitinib-resistant cells in wild-type HCC827 cells,.

To discover potential biomarkers for accurate discrimination of gefitinib-resistant and gefitinib-sensitive cells, four single cells were selected to compare their lipid C=C location isomer compositions, i.e., Cell #1: HCC827, gefitinib-sensitive; Cell #2: HCC827/GR6, gefitinib-resistant; Cell #3: HCC827, gefitinib-resistant; and Cell #4: HCC827/GR6, gefitinib-sensitive (Fig. 5c, f). At the cell population level, the relative abundance of PC 32:1 with C16:1(Δ9) or C18:1(Δ11) in gefitinib-sensitive cells (55.7 ± 4.9%) was higher than that (41.0 ± 5.1%) in gefitinib-resistant cells (P < 0.001, determined by single-tailed t-test) (Fig. 5e). Cells #1 and #3 were both from HCC827 cell line: Cell #1 had a proportion of 55.1% of PC 32:1 with C16:1(Δ9) or C18:1(Δ11) and was classified as gefitinib-sensitive, while Cell #3 has a proportion of 42.7% and was classified as gefitinib-resistant. Similarly, Cells #2 and #4 were both from the HCC827/GR6 cell line: Cell #2 has a proportion of 43.4% and was classified as gefitinib-resistant, while Cell #4 has a proportion of 52.1% and was classified as gefitinib-sensitive. Such differences in the relative amounts of PC 32:1 C=C location isomers between gefitinib-resistant and gefitinib-sensitive cells can be readily seen from the PB-MS/MS spectrum (Supplementary Fig. 25). All these results demonstrated that the highly discriminating capability towards drug-resistant cells from an otherwise homogeneous HCC827 cell population cannot be achieved without single-cell structural lipid analysis at C=C location level.

Discussion

Through this study, we have demonstrated an effective strategy that allows a shotgun lipidomics analysis of single cells with high structural specificity. The cell fixation confined lipids in the cell, which avoided sample dilution and cross-contamination during cell manipulation and batch derivatization. This also lays the foundation for high-throughput single-cell MS analysis. The combination with DAESI promoted single-cell MS analysis to a higher level with structural specificity of the lipidome as well as with high flexibility and sensitivity. From the lipid isomer level, we compared the heterogeneity degree differences among four types of human breast cancer cell lines. Most importantly, our method can reveal inter-cellular heterogeneities among cells in the same population. Gefitinib-resistant single cells could only be discriminated from wild-type NSCLC cell population by lipid C=C location isomer relative quantitation. We believe that chemical derivatization coupled with tandem MS analysis is not only a feasible routine for the structural characterization of biomolecules in single cells, but also a driving force for single-cell biology, cancer pathology, and precision medicine.

Sample preparation

Lipid standards, including PC 15:0-15:0, PE 15:0-15:0 were purchased from Avanti Polar Lipids, Inc. (Alabaster, AL, USA). Acetylpyridines (including 2-AP, 3-AP, and 4-AP) were purchased from Aladdin Biological Technology Company, Ltd. (Shanghai, China). The low-pressure mercury lamp with UV emission centered around 254 nm (Model No. 80-1057-01) was purchased from BHK Inc. (Seongnam-SI, Korea). Dulbecco’s modified Eagle medium (DMEM), Leibovitz’s L-15 medium, phosphate-buffered saline (PBS) solution (10 mM, pH 7.4), Roswell Park Memorial Institute-1640 medium (RPMI), fetal bovine serum (FBS), and Dulbecco’s phosphate-buffered saline (DPBS) were purchased from Gibco Life Technologies (Carlsbad, CA, USA). CAY10566 was purchased from MedChem Express (Monmouth Junction, NJ, USA).

MCF-7 cells were purchased from National Infrastructure of Cell Line Resource (Beijing, China). BT-474, MDA-MB-468, and MDA-MB-231 were obtained from Shanghai Enzyme Research Biotechnology Co. Ltd. (Shanghai, China). MCF-7 and BT-474 cells were cultured in DMEM and RPMI, respectively. MDA-MB-468 and MDA-MB-231 cells were cultured in Leibovitz’s L-15 medium. All cells were supplemented with 10% FBS and 1% penicillin-streptomycin. MDA-MB-468 and MDA-MB-231 cells were cultured with sealed culturing dish while the rest of cells were cultured in breathable dish at 37 °C in a humidified atmosphere containing 5% CO2. Cells were washed with DPBS (2 mL) and passaged by trypsinization when they reached 85−90% confluence. For SCD1 inhibition, MDA-MB-468 cells were treated with 100 nM CAY10566 for 3 days, while the control group was treated with DMSO. HCC827 and HCC827/GR6 cells used in this study are kind gifts from Dr. Pasi A. Jänne (Dana-Farber Cancer Institute, Boston, MA). Cell lines were authenticated via short tandem repeat (STR) testing by Genesky Biopharma Technology (Shanghai, China). Cells were maintained in appropriate culture medium, as suggested by the supplier.

After washing with PBS, cells (~106 cells/mL) were suspended in 2.5% glutaraldehyde in PBS for 20 min in a shaker. Cells were then washed twice. For direct single-cell analysis, cells were resuspended in water and diluted to a concentration of 104 cells/mL. For cell derivatization, cells (~106 cells/mL) were resuspended in 100 mM 2-AP aqueous solution. The device for cell derivatization is shown in Fig. 1c. And after 2 min UV irradiation, the quartz cell was taken out and shaken gently for even cell distribution. This process was repeated 4 times, reaching a reaction time of 8 min. Derivatized cells were washed twice using water to remove excess 2-AP and finally diluted to a concentration of 104 cells/mL. The fixation of the cell population (e.g., 106 cells) requires 20 min, the PB derivatization needs 8 min, and the cell washing using centrifugation requires another 10 min, bringing the total time of cell preparation to around 40 min. These extra steps are necessary to acquire detailed lipid structures, e.g., C=C locations, but performed to the cell population so the time of cell preparation would not increase as the number of cells increases.

A modified Folch method was used for lipid extraction from the cell population. Harvested cells were divided into two equal subsets. One subset was treated with 2.5% glutaraldehyde in PBS for fixation while the other subset was treated with PBS as a control. After centrifugation, cells were resuspended in 1 mL deionized water in a 10 mL centrifuge tube, followed by addition of 1 mL methanol and 2 mL chloroform. The internal standard (PC 15:0/15:0 and PE 15:0/15:0) was added at a concentration of 5 μM. After 5 min vortexing, the mixture was centrifuged at 11,269g for 8 min. Then, a second round of lipid extraction was performed. The chloroform layers from the two extractions were finally combined and dried under nitrogen flow. The lipid extract was reconstituted in 500 μL methanol and stored at −20 °C for MS analysis.

The stainless-steel electrode (o.d. = 120 μm) was purchased from HAMILTON Company (Reno, NV, USA) and the borosilicate glass capillaries (i.d. = 0.86 mm, o.d. = 1.5 mm) were purchased from Sutter Instrument (Novato, CA, USA). Borosilicate glass capillaries were washed with 1% formic acid (v/v) in ethanol:water = 1:1 twice, and then pulled to make nanoESI emitters (i.d. of the opening ≈ 5~10 μm) for MS analysis, using a P-1000 micropipette puller (Sutter Instrument, Novato, CA, USA). P-1000 parameters are as follows: HEAT = 535, PULL = 0, VEL = 15, DELAY = 1, Pressure = 600, and Ramp = 530.

Single-cell MS analysis

Around 0.5 of cell suspension was transferred to a nanospray capillary. A DC voltage of −1.3 kV was applied via a stainless-steel electrode for several seconds to promote electro-migration. After solvent evaporation, a droplet (~50 μL) of assistant solvent (methanol:acetonitrile = 1:1 (v/v) with 1% formic acid) was applied to the capillary tip. Meanwhile, a voltage of +1.8 kV was applied to initiate on-demand MS analysis. For PB-MS/MS analysis, multiple droplets were dropped sequentially to the nanoESI tip to analyze different lipid species. It took 1~2 min to transfer a single cell to the capillary and perform electro-migration, 3~5 min to evaporate the liquid in the tip, and 4~6 min for multi-rounds sampling and data acquisition. For lipid sum compositions analysis, a droplet of 10 mM LiCl in methanol:acetonitrile = 1:1(v/v) and a voltage of +1.5 kV were applied for DAESI. For negative MS/MS analysis to confirm fatty acyl-chains, a droplet of 50 mM ammonium acetate solvent in methanol:acetonitrile:water = 4.5:4.5:1 (v/v) and a voltage of −1.8 kV were applied for DAESI. For sn-position identification, a droplet of 50 mM ammonium bicarbonate solvent in methanol:acetonitrile:water = 4.5:4.5:1 (v/v) and a voltage of −1.8 kV were applied for DAESI. All MS analysis was performed by QTRAP 4500 mass spectrometer (Sciex, Toronto, CA).

Data processing

The recovery ratio of PCs after fixation is defined as follows:

The conversion yield of PB reaction is defined as follows:

Pairwise correlation coefficients in Fig. 2e and Supplementary Fig. 3 were calculated by the intensities of PB product ions (Supplementary Table 2) of each spray. The intensities of C=C-specific diagnostic ions are used for quantifying lipid C=C location isomers. The S/N ratio of the diagnostic ions should be >10 for quantitation. For a lipid containing n C=Cs, its relative amount is represented by the total intensities of all dignostic ions, divided by n. Below, we use PC 36:2 as an example to show the calculation,

Two-tailed t-test was performed to evaluate the changes of the average of relative amounts of PC C=C location isomers and F-test was performed to evaluate the changes of the variances. All MS data were collected and processed by Analyst 1.6.3 from Sciex. All data processing including distribution fitting, t-test, F-test, t-SNE calculation, and k-means clustering were performed using MATLAB 2019b.

Reporting summary

Further information on research design is available in the Nature Research Reporting Summary linked to this article.

References 66

  1. 1.

    Stuart T, Satija R. Integrative single-cell analysis. Nat. Rev. Genet. 2019;20:257-272.

    Not in our library10.1038/s41576-019-0093-7

  2. 2.

    Neumann EK, Do TD, Comi TJ, Sweedler JV. Exploring the fundamental structures of life: non-targeted, chemical analysis of single cells and subcellular structures. Angew. Chem. Int. Ed. Engl. 2019;58:9348-9364.

    Not in our library10.1002/anie.201811951

  3. 3.

    Wilson PC, et al. The single-cell transcriptomic landscape of early human diabetic nephropathy. Proc. Natl Acad. Sci. USA. 2019;116:19619-19625.

    Not in our library10.1073/pnas.1908706116

  4. 4.

    Voigt AP, et al. Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration. Proc. Natl Acad. Sci. USA. 2019;116:24100-24107.

    Not in our library10.1073/pnas.1914143116

  5. 5.

    Palii CG, et al. Single-cell proteomics reveal that quantitative changes in co-expressed lineage-specific transcription factors determine cell fate. Cell Stem Cell. 2019;24:812-820.e815.

    Not in our library10.1016/j.stem.2019.02.006

  6. 6.

    Li H, et al. Adaptable microfluidic system for single-cell pathogen classification and antimicrobial susceptibility testing. Proc. Natl Acad. Sci. USA. 2019;116:10270-10279.

    Not in our library10.1073/pnas.1819569116

  7. 7.
  8. 8.

    Good Z, et al. Proliferation tracing with single-cell mass cytometry optimizes generation of stem cell memory-like T cells. Nat. Biotechnol. 2019;37:259-266.

    Not in our library10.1038/s41587-019-0033-2

  9. 9.

    Thiele C, Wunderling K, Leyendecker P. Multiplexed and single cell tracing of lipid metabolism. Nat. Methods. 2019;16:1123-1130.

    Not in our library10.1038/s41592-019-0593-6

  10. 10.

    Huang B, et al. Counting low-copy number proteins in a single cell. Science. 2007;315:81-84.

    Not in our library10.1126/science.1133992

  11. 11.

    Zenobi R. Single-cell metabolomics: analytical and biological perspectives. Science. 2013;342:1243259.

    Not in our library10.1126/science.1243259

  12. 12.

    Ibanez AJ, et al. Mass spectrometry-based metabolomics of single yeast cells. Proc. Natl Acad. Sci. USA. 2013;110:8790-8794.

    Not in our library10.1073/pnas.1209302110

  13. 13.

    Zhang L, Vertes A. Single-cell mass spectrometry approaches to explore cellular heterogeneity. Angew. Chem. Int Ed. Engl. 2018;57:4466-4477.

    Not in our library10.1002/anie.201709719

  14. 14.

    Zhang XC, et al. Combination of droplet extraction and pico-ESI-MS allows the identification of metabolites from single cancer cells. Anal. Chem. 2018;90:9897-9903.

    Not in our library10.1021/acs.analchem.8b02098

  15. 15.

    Feng J, et al. Quantitation of glucose-phosphate in single cells by microwell-based nanoliter droplet microextraction and mass spectrometry. Anal. Chem. 2019;91:5613-5620.

    Not in our library10.1021/acs.analchem.8b05226

  16. 16.

    Neumann EK, Comi TJ, Rubakhin SS, Sweedler JV. Lipid heterogeneity between astrocytes and neurons revealed by single-cell MALDI-MS combined with immunocytochemical classification. Angew. Chem. Int. Ed. Engl. 2019;58:5910-5914.

    Not in our library10.1002/anie.201812892

  17. 17.

    Standke SJ, Colby DH, Bensen RC, Burgett AWG, Yang Z. Mass spectrometry measurement of single suspended cells using a combined cell manipulation system and a single-probe device. Anal. Chem. 2019;91:1738-1742.

    Not in our library10.1021/acs.analchem.8b05774

  18. 18.

    Zhao Y, et al. Separating and profiling phosphatidylcholines and triglycerides from single cellular lipid droplet by in-tip solvent microextraction mass spectrometry. Anal. Chem. 2019;91:4466-4471.

    Not in our library10.1021/acs.analchem.8b05122

  19. 19.

    Fujii T, et al. Direct metabolomics for plant cells by live single-cell mass spectrometry. Nat. Protoc. 2015;10:1445-1456.

    Not in our library10.1038/nprot.2015.084

  20. 20.

    Zhu H, et al. Single-neuron identification of chemical constituents, physiological changes, and metabolism using mass spectrometry. Proc. Natl Acad. Sci. USA. 2017;114:2586-2591.

    Not in our library10.1073/pnas.1615557114

  21. 21.

    Rustam YH, Reid GE. Analytical challenges and recent advances in mass spectrometry based lipidomics. Anal. Chem. 2018;90:374-397.

    Not in our library10.1021/acs.analchem.7b04836

  22. 22.

    Ma X, Xia Y. Pinpointing double bonds in lipids by Paterno-Buchi reactions and mass spectrometry. Angew. Chem. Int. Ed. Engl. 2014;53:2592-2596.

    Not in our library10.1002/anie.201310699

  23. 23.

    Murphy RC, Okuno T, Johnson CA, Barkley RM. Determination of double bond positions in polyunsaturated fatty acids using the photochemical Paterno-Buchi reaction with acetone and tandem mass spectrometry. Anal. Chem. 2017;89:8545-8553.

    Not in our library10.1021/acs.analchem.7b02375

  24. 24.

    Esch P, Heiles S. Charging and charge switching of unsaturated lipids and apolar compounds using Paterno-Buchi reactions. J. Am. Soc. Mass Spectrom. 2018;29:1971-1980.

    Not in our library10.1007/s13361-018-2023-x

  25. 25.

    Zhao X, et al. A lipidomic workflow capable of resolving sn- and C[double bond, length as m-dash]C location isomers of phosphatidylcholines. Chem. Sci. 2019;10:10740-10748.

    Not in our library10.1039/c9sc03521d

  26. 26.
  27. 27.

    Zhao Y, et al. Identification and quantitation of C horizontal lineC location isomers of unsaturated fatty acids by epoxidation reaction and tandem mass spectrometry. Anal. Chem. 2017;89:10270-10278.

    Not in our library10.1021/acs.analchem.7b01870

  28. 28.

    Cao W, Ma X, Li Z, Zhou X, Ouyang Z. Locating carbon–carbon double bonds in unsaturated phospholipids by epoxidation reaction and tandem mass spectrometry. Anal. Chem. 2018;90:10286-10292.

    Not in our library10.1021/acs.analchem.8b02021

  29. 29.

    Zhao X, et al. Rapid analysis of unsaturated fatty acids on paper-based analytical devices via online epoxidation and ambient mass spectrometry. Anal. Chem. 2018;90:2070-2078.

    Not in our library10.1021/acs.analchem.7b04312

  30. 30.

    Feng Y, Chen B, Yu Q, Li L. Identification of double bond position isomers in unsaturated lipids by m-CPBA epoxidation and mass spectrometry fragmentation. Anal. Chem. 2019;91:1791-1795.

    Not in our library10.1021/acs.analchem.8b04905

  31. 31.

    Kuo TH, et al. Deep lipidomics and molecular imaging of unsaturated lipid isomers: a universal strategy initiated by mCPBA epoxidation. Anal. Chem. 2019;91:11905-11915.

    Not in our library10.1021/acs.analchem.9b02667

  32. 32.

    Ma X, et al. Identification and quantitation of lipid C=C location isomers: a shotgun lipidomics approach enabled by photochemical reaction. Proc. Natl Acad. Sci. USA. 2016;113:2573-2578.

    Not in our library10.1073/pnas.1523356113

  33. 33.

    Ma X, et al. Photochemical tagging for quantitation of unsaturated fatty acids by mass spectrometry. Anal. Chem. 2016;88:8931-8935.

    Not in our library10.1021/acs.analchem.6b02834

  34. 34.
  35. 35.

    Lin Q, Zhang D, Xia Y. Analysis of ether glycerophosphocholines at the level of C[double bond, length as m-dash]C locations from human plasma. Analyst. 2020;145:513-522.

    Not in our library10.1039/c9an01515a

  36. 36.

    Zhang W, et al. A polymer coating transfer enrichment method for direct mass spectrometry analysis of lipids in biofluid samples. Angew. Chem. Int. Ed. Engl. 2019;58:6064-6069.

    Not in our library10.1002/anie.201900011

  37. 37.

    Ekroos K, et al. Charting molecular composition of phosphatidylcholines by fatty acid scanning and ion trap MS3 fragmentation. J. Lipid Res. 2003;44:2181-2192.

    Not in our library10.1194/jlr.d300020-jlr200

  38. 38.

    Ellis SR, et al. Direct lipid profiling of single cells from inkjet printed microarrays. Anal. Chem. 2012;84:9679-9683.

    Not in our library10.1021/ac302634u

  39. 39.

    Chen F, et al. Single-cell analysis using drop-on-demand inkjet printing and probe electrospray ionization mass spectrometry. Anal. Chem. 2016;88:4354-4360.

    Not in our library10.1021/acs.analchem.5b04749

  40. 40.

    Pan N, et al. The single-probe: a miniaturized multifunctional device for single cell mass spectrometry analysis. Anal. Chem. 2014;86:9376-9380.

    Not in our library10.1021/ac5029038

  41. 41.

    Liu R, Pan N, Zhu Y, Yang Z. T-probe: an integrated microscale device for online in situ single cell analysis and metabolic profiling using mass spectrometry. Anal. Chem. 2018;90:11078-11085.

    Not in our library10.1021/acs.analchem.8b02927

  42. 42.

    Passarelli MK, Ewing AG, Winograd N. Single-cell lipidomics: characterizing and imaging lipids on the surface of individual Aplysia californica neurons with cluster secondary ion mass spectrometry. Anal. Chem. 2013;85:2231-2238.

    Not in our library10.1021/ac303038j

  43. 43.

    Xie W, Gao D, Jin F, Jiang Y, Liu H. Study of phospholipids in single cells using an integrated microfluidic device combined with matrix-assisted laser desorption/ionization mass spectrometry. Anal. Chem. 2015;87:7052-7059.

    Not in our library10.1021/acs.analchem.5b00010

  44. 44.

    Yao H, et al. Label-free mass cytometry for unveiling cellular metabolic heterogeneity. Anal. Chem. 2019;91:9777-9783.

    Not in our library10.1021/acs.analchem.9b01419

  45. 45.

    Bednarik A, Bolsker S, Soltwisch J, Dreisewerd K. An on-tissue Paterno-Buchi reaction for localization of carbon–carbon double bonds in phospholipids and glycolipids by matrix-assisted laser-desorption-ionization mass-spectrometry imaging. Angew. Chem. Int. Ed. Engl. 2018;57:12092-12096.

    Not in our library10.1002/anie.201806635

  46. 46.

    Wäldchen F, Spengler B, Heiles S. Reactive matrix-assisted laser desorption/ionization mass spectrometry imaging using an intrinsically photoreactive Paternò–Büchi matrix for double-bond localization in isomeric phospholipids. J.Am.Chem. Soc. 2019;141:11816-11820.

    Not in our library10.1021/jacs.9b05868

  47. 47.

    Zhu Y, Wang W, Yang Z. Combining mass spectrometry with Paterno-Buchi reaction to determine double-bond positions in lipids at the single-cell level. Anal. Chem. 2020;92:11380-11387.

    Not in our library10.1021/acs.analchem.0c02245

  48. 48.

    Li Z, et al. Single-cell mass spectrometry analysis of metabolites facilitated by cell electro-migration and electroporation. Anal. Chem. 2020;92:10138-10144.

    Not in our library10.1021/acs.analchem.0c02147

  49. 49.

    Hopwood D. Theoretical and practical aspects of glutaraldehyde fixation. Histochem. J. 1972;4:267-303.

    Not in our library10.1007/bf01005005

  50. 50.

    Gong X, et al. Desalting by crystallization: detection of attomole biomolecules in picoliter buffers by mass spectrometry. Anal. Chem. 2015;87:9745-9751.

    Not in our library10.1021/acs.analchem.5b01877

  51. 51.

    Zhang XC, et al. Integrated droplet-based microextraction with ESI-MS for removal of matrix interference in single-cell analysis. Sci. Rep. 2016;6:24730.

    Not in our library10.1038/srep24730

  52. 52.

    Han X, Gross RW. Electrospray ionization mass spectroscopic analysis of human erythrocyte plasma membrane phospholipids. Proc. Natl Acad. Sci. USA. 1994;91:10635-10639.

    Not in our library10.1073/pnas.91.22.10635

  53. 53.

    Xie X, Zhao J, Lin M, Zhang JL, Xia Y. Profiling of cholesteryl esters by coupling charge-tagging Paterno-Buchi reaction and liquid chromatography-mass spectrometry. Anal. Chem. 2020;92:8487-8496.

    Not in our library10.1021/acs.analchem.0c01241

  54. 54.

    Harbeck N, et al. Breast cancer. Nat. Rev. Dis. Prim. 2019;5:66.

    Not in our library10.1038/s41572-019-0111-2

  55. 55.

    Dai X, Cheng H, Bai Z, Li J. Breast cancer cell line classification and its relevance with breast tumor subtyping. J. Cancer. 2017;8:3131-3141.

    Not in our library10.7150/jca.18457

  56. 56.

    Doria ML, et al. Lipidomic analysis of phospholipids from human mammary epithelial and breast cancer cell lines. J. Cell Physiol. 2013;228:457-468.

    Not in our library10.1002/jcp.24152

  57. 57.

    Eiriksson FF, et al. Lipidomic study of cell lines reveals differences between breast cancer subtypes. PLoS ONE. 2020;15:e0231289.

    Not in our library10.1371/journal.pone.0231289

  58. 58.
  59. 59.

    Lombard-Banek C, Moody SA, Nemes P. Single-cell mass spectrometry for discovery proteomics: quantifying translational cell heterogeneity in the 16-cell frog (Xenopus) embryo. Angew. Chem. Int. Ed. Engl. 2016;55:2454-2458.

    Not in our library10.1002/anie.201510411

  60. 60.

    Loo LH, et al. An approach for extensibly profiling the molecular states of cellular subpopulations. Nat. Methods. 2009;6:759-765.

    Not in our library10.1038/nmeth.1375

  61. 61.

    Moding EJ, et al. Circulating tumor DNA dynamics predict benefit from consolidation immunotherapy in locally advanced non-small-cell lung cancer. Nat. Cancer. 2020;1:176-183.

    Not in our library10.1038/s43018-019-0011-0

  62. 62.

    Muhsin M, Graham J, Kirkpatrick P. Gefitinib. Nat. Rev. Cancer. 2003;3:556-557.

    Not in our library10.1038/nrc1159

  63. 63.

    Engelman JA, et al. MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science. 2007;316:1039-1043.

    Not in our library10.1126/science.1141478

  64. 64.

    Shen A, et al. c-Myc alterations confer therapeutic response and acquired resistance to c-Met inhibitors in MET-addicted cancers. Cancer Res. 2015;75:4548.

    Not in our library10.1158/0008-5472.can-14-2743

  65. 65.
  66. 66.

    Yoshida T, et al. Effects of Src inhibitors on cell growth and epidermal growth factor receptor and MET signaling in gefitinib-resistant non-small cell lung cancer cells with acquired MET amplification. Cancer Sci. 2010;101:167-172.

    Not in our library10.1111/j.1349-7006.2009.01368.x

Cited by papers we hold 2

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.